Nitric oxide/cyclic guanosine monophosphate system in the spinal cord differentially modulates intracerebroventricularly administered morphine- and beta-endorphin-induced antinociception in the mouse

JY Xu and LF Tseng

Department of Anesthesiology, Medical College of Wisconsin, Milwaukee, USA.

Our study was designed to study the modulatory role of nitric oxide/cyclic guanosine monophosphate in the spinal cord on the antinociception induced by morphine and beta-endorphin given supraspinally. The antinociception was assessed by the tail-flick test in male ICR mice. The antinociception induced by intracerebroventricularly (i.c.v.) administered morphine was potentiated by intrathecal (i.t) injection of N omega-nitro-L-arginine (2 micrograms), hemoglobin (120 micrograms) or methylene blue (5 micrograms), but was attenuated by i.t. administered L-arginine (20 micrograms) or 3-morpholino-sydnonimine (SIN-1, 5 micrograms). In contrast, the antinociception induced by i.c.v. administered beta- endorphin was attenuated by i.t. pretreatment with N omega-nitro-L- arginine (2 micrograms) and the attenuation of beta-endorphin-induced antinociception by N omega-nitro-L-arginine was reversed by i.t. administered L-arginine (20 micrograms). The antinociception induced by i.c.v. administered beta-endorphin was also attenuated by i.t. administration of hemoglobin (120 micrograms) or methylene blue (5 micrograms). Intrathecal pretreatment with L-arginine did not affect i.c.v. administered beta-endorphin-induced antinociception. It is concluded that the inhibition of nitric oxide/cyclic guanosine monophosphate system in the spinal cord potentiates i.c.v. administered morphine-induced antinociception but attenuates i.c.v. beta-endorphin- induced antinociception. The activation of nitric oxide/cyclic guanosine monophosphate system in the spinal cord attenuates i.c.v. administered morphine-induced antinociception but does not affect i.c.v. administered beta-endorphin-induced antinociception.

Volume 274, Issue 1, pp. 8-16, 07/01/1995
Copyright © 1995 by American Society for Pharmacology and Experimental Therapeutics

This article has been cited by other articles:

				H. Teschemacher Lactoferrin elicits opioid-mediated antinociception without development of tolerance: central nNOS-1 set off duty? Am J Physiol Regulatory Integrative Comp Physiol, August 1, 2003; 285(2): R302 - R305. [Full Text] [PDF]

				J. Y. Xu, K. P. Hill, and J. M. Bidlack The Nitric Oxide/Cyclic GMP System at the Supraspinal Site Is Involved in the Development of Acute Morphine Antinociceptive Tolerance, J. Pharmacol. Exp. Ther., January 1, 1998; 284(1): 196 - 201. [Abstract] [Full Text]

				H. Machelska Inhibition of Nitric Oxide Synthase Enhances Antinociception Mediated by Mu, Delta and Kappa Opioid Receptors in Acute and Prolonged Pain in the Rat Spinal Cord J. Pharmacol. Exp. Ther., August 1, 1997; 282(2): 977 - 984. [Abstract] [Full Text]

				H. N. Bhargava, J.-T. Bian, and S. Kumar Mechanism of Attenuation of Morphine Antinociception by Chronic Treatment with L-Arginine J. Pharmacol. Exp. Ther., May 1, 1997; 281(2): 707 - 712. [Abstract] [Full Text]